Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCPS | Q96C86 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1450085 | 1.00 | DCPS (0.36) | DCPSADORA2APDPK1GDACASP1 | |
| Hydrochloric Acid SCHEMBL19858968 | 1.00 | DCPS (0.36) | DCPSADORA2APDPK1GDACASP1 | |
| Hydrochloric Acid SCHEMBL19858969 | 1.00 | DCPS (0.36) | DCPSADORA2APDPK1GDACASP1 | |
| SCHEMBL33841 | 0.96 | DCPS (0.38) | DCPSADORA2APDPK1GDACASP1 | |
| Bromide SCHEMBL62601 | 0.92 | DCPS (0.36) | DCPSADORA2APDPK1GDACASP1 | |
| Bromide SCHEMBL7862403 | 0.92 | DCPS (0.36) | DCPSADORA2APDPK1GDACASP1 | |
| Bromide SCHEMBL62599 | 0.92 | DCPS (0.36) | DCPSADORA2APDPK1GDACASP1 | |
| SCHEMBL6944829 | 0.81 | PIK3CG (0.31) | DCPSADORA2APDPK1 | |
| SCHEMBL6943391 | 0.78 | CYP1A2 (0.31) | DCPSADORA2APDPK1CASP1 | |
| Sulfuric Acid SCHEMBL20815930 | 0.78 | PDPK1 (0.34) | DCPSADORA2APDPK1CCNA2CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3634365-B1 | HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE | HENKEL AG & CO KGAA (DE) | 2022-08-10 | — | — | EP | claimed |
| EP-3496818-B1 | PROCESS FOR PREPARING HAIR DYE AGENTS HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES | HENKEL AG & CO KGAA (DE) | 2021-01-20 | — | — | EP | claimed |
| US-10736827-B2 | Hair dye agent having unilamellar and multilamellar vesicles | HENKEL AG & CO. KGAA (DE) | 2020-08-11 | — | — | US | claimed |
| US-20200170904-A1 | HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE | HENKEL AG & CO. KGAA (DE) | 2020-06-04 | — | — | US | claimed |
| EP-3634365-A1 | HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE | Henkel AG & Co. KGaA (DE) | 2020-04-15 | — | — | EP | claimed |
| US-20190175459-A1 | HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES | HENKEL AG & CO. KGAA (DE) | 2019-06-13 | — | — | US | claimed |
| WO-2018224244-A1 | HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE | HENKEL AG & CO. KGAA (DE) | 2018-12-13 | — | — | WO | claimed |
| EP-3634365-B1 | HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE | HENKEL AG & CO KGAA (DE) | 2022-08-10 | — | — | EP | disclosed |
| EP-3496818-B1 | PROCESS FOR PREPARING HAIR DYE AGENTS HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES | HENKEL AG & CO KGAA (DE) | 2021-01-20 | — | — | EP | disclosed |
| US-10736827-B2 | Hair dye agent having unilamellar and multilamellar vesicles | HENKEL AG & CO. KGAA (DE) | 2020-08-11 | — | — | US | disclosed |
| US-10702459-B2 | Hair dye having improved viscosity stability | HENKEL AG & CO. KGAA (DE) | 2020-07-07 | — | — | US | disclosed |
| US-20200170904-A1 | HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE | HENKEL AG & CO. KGAA (DE) | 2020-06-04 | — | — | US | disclosed |
| EP-3634365-A1 | HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE | Henkel AG & Co. KGaA (DE) | 2020-04-15 | — | — | EP | disclosed |
| CN-1439641-A | Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science | CHINESE PHARMACEUTICAL UNIV (CN) | 2003-09-03 | — | — | CN | disclosed |
| EP-1144412-A1 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | K.U. Leuven Research & Development (BE) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000039129-A1 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2000-07-06 | — | — | WO | disclosed |
| WO-1997021711-A1 | PROCESS FOR PREPARING 4-AMINOPTERIDINE DERIVATIVES | LONZA AG (CH) | 1997-06-19 | — | — | WO | disclosed |
| US-4079056-A | REACTING 2,4-DIAMINO-6-PTERIDINE-METHANOL-HBR WITH TRIPHENYLPHOSPHINE DIBROMIDE OR PHOSPHORUS TRIBROMIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1978-03-14 | — | — | US | disclosed |
| US-4077957-A | INTERMEDIATE FOR METHOTREXATE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1978-03-07 | — | — | US | disclosed |
| US-3989703-A | Process of preparing N[p-{[(2,4-diamino-6-pteridyl)-methyl]N10 -methylamino}-benzoyl]-glutamic acid | INSTITUTUL ONCOLOGIC (RU) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10736827-B2 | Hair dye agent having unilamellar and multilamellar vesicles | EXOSC10, ANXA5, ANXA4 | DCPS 3780/4885ADORA2A 3267/4885PDPK1 4062/4885 |
| US-20200170904-A1 | HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE | UGCG, ADH1C, ELOVL1 | DCPS 3231/4885ADORA2A 4269/4885PDPK1 4090/4885 |
| US-10702459-B2 | Hair dye having improved viscosity stability | KRT18, S100B, SHH | DCPS 3724/4885ADORA2A 3948/4885PDPK1 4753/4885 |
| US-20190175459-A1 | HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES | EXOSC10, ANXA5, ANXA4 | DCPS 3780/4885ADORA2A 3267/4885PDPK1 4062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.